IRRITABLE BOWEL SYNDROME TREATMENT MARKET ANALYSIS

Irritable Bowel Syndrome Treatment Market, by Drug Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, and Others), by Medical Condition (IBS-constipation and IBS-diarrhea), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jun 2022
Code : CMI506
Pages :156
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Global Irritable Bowel Syndrome Treatment Market: Restraint

The major factors that hinder growth of the global irritable bowel syndrome treatment market include side effects of the drugs. For instance, Eluxadoline, a mixed mu-opioid receptor agonist, used to treat irritable bowel syndrome with diarrhea can cause pancreatitis, an inflammation of the pancreas which can be serious and more common in certain individuals.

Restraints & Challenges: